knowledge -WSS

knowledge

author：entertainment 2025-08-12 08:25:21 - browse：76

Illustration oh researchers look up at a blister pill pac. Part of the blister pack is filled with pills, while the center shows a sketch of a brain. -- biotech coverage from STAT — Mike Reddy for STAT

One by one, the companies behind Zoloft, Prozac, and Paxil soured on psychiatry.

It was the early 2000s, and as America warmed to the sounds of Sisqó and Shakira, the world’s largest pharmaceutical firms were running out of ideas to treat mental illness. Their blockbuster treatments for depression and schizophrenia had reshaped society and made billions of dollars in the process, but the old cash cows were soon to go generic. Efforts to one-up the last generation of drugs mostly resulted in incremental changes to aging medicines. And when insurance companies balked at paying brand-name prices for extended-release generics, the money dried up and the industry moved out.

“The mindset of Big Pharma in those days was one pill for millions and millions of people,” said John LaMattina, who led Pfizer’s research division from 1999 to 2007. “Everyone was looking for the next Lipitor, and when that fizzled out, there was an exodus out of psychotherapeutic areas.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Vertex Pharmaceuticals may move headquarters in Boston

WSS

Readout Newsletter: Merck, Vertex, and Viking updates

Readout Newsletter: Cardior, Regeneron, Nuvation, Dyne and more

Steward Health Care has deal to sell doctor network to UnitedHealth

Primary care physicians play key roles in Alzheimer's management

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

The stability of $0 premiums in Medicare Advantage

hotspot

knowledge

leisure time

United colonoscopy coverage change 'may cost lives,' doctors say

Vertex Pharmaceuticals may move headquarters in Boston

Medical records are filled with copy

FDA's naming rule on biosimilars has undermined competition

Cancer drug shortages should be causing more outrage

Why the world’s most expensive drug might be worth the price

Heart attack and stroke risk calculators need revising

Why the world’s most expensive drug might be worth the price

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Washington mulls new rules to avert another Change Healthcare

knowledge

Health insurers' Q3 question: how much care are people getting?

The Readout: Lenmeldy, GLP

Patient advocates debate FDA's accelerated approval process

Flu, Covid vaccination rates decline, new survey data show

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Study points to new risk in gene therapy death of Terry Horgan

leisure time

hotspot

focus

entertainment